###BASE_URL###
2010-04-16 | permalink
The main benefactor of the Environmental Risk Management Authority’s (ERMA) decision to allow the application by Crown Research Institute AgResearch a carte blanche application to genetically engineer (GE) cattle, sheep and goats using a huge range of E.coli bacteria, human, mouse, sheep, goats, cattle, and viruses and other material is the United States biotech company GTC Biotherapeutics (GTC), an off shoot of Genzyme Corporation, according to the Soil & Health Association.
2010-04-15 | permalink
AgResearch has been granted approval to continue genetic engineering research on goats, sheep and cattle, using human DNA, to produce human therapeutic proteins in milk. The state-owned science company received approval from the Environmental Risk Management Authority (Erma) to genetically modify bacterial and mammalian cells, mice, goats, sheep and cattle at its Ruakura facility, near Hamilton. Controls were imposed to prevent animal products from reaching the food chain.
2010-04-06 | permalink
The replacement enzymes are currently made by genetic modification of Chinese hamster ovary (CHO) cells, but may one day come from the milk of carefully modified New Zealand cows, which is why Forman has made a submission in support of AgResearch’s application in March to develop genetically modified goats, sheep and cows to produce human therapeutic proteins.
2010-03-18 | permalink
[Framingham-based GTC Biotherapeutics] that produces drugs made from the milk of genetically-engineered goats says it expects to be delisted from the Nasdaq next week. [...] it does not expect to regain compliance with minimum listing rules for the stock exchange, which require companies to have at least $35 million in market capital.
2010-03-03 | permalink
Organic farmers fear ”brand New Zealand” will be damaged if plans proceed to expand the range of genetically modified animals. Farmers and exporters told a panel deciding whether to allow Agresearch to put human genes into goats, sheep and cows that overseas customers might stop buying New Zealand products if there were further trials.
2010-02-26 | permalink
A proposal to put human genes into goats, sheep and cows to try to get the animals to make human proteins in their milk will be in the public spotlight next week. Submitters will have Monday and Tuesday to tell the Environmental Risk Management Authority what they think of plans by AgResearch to breed and keep genetically modified animals at its Ruakura research facility, near Hamilton.
2009-11-18 | permalink
GTC Biotherapeutics of Framingham said it will reduce its work force from 154 to 109 people as part of an effort to improve its financial position and meet Nasdaq compliance requirements. The company saw its loss from operations rise to $9.5 million in the third quarter of the year, compared with a $5.8 million loss for the same quarter last year. Its total loss fell from $6.1 million to $5.1 million, thanks to extra income that the company attributed to a mark-to-market adjustment of its stock.
2009-11-18 | permalink
AgResearch plans to alter the make-up of cows, sheep and goats to produce a medicinal super-milk by mixing human and animal DNA. The Crown research institute is pushing ahead with the plans, despite being embroiled in a court battle with GE-Free New Zealand over similar proposals that the lobby group says show ”callous disregard” for the environment and economy.
2009-11-06 | permalink
AgResearch has submitted a limited application to ERMA for specific research using genetically modified goats, sheep and cattle in containment. This is necessary so that AgResearch can meet contractual requirements. In 2008 AgResearch applied to ERMA for four new approvals to continue the transgenic livestock programme for a number of species and a range of activities, from pure scientific research, to maintaining transgenic animals in containment
2009-09-04 | permalink
Dutch biotech firm Pharming said on Thursday it had lodged its application for marketing approval for its lead product Rhucin with the European Medicines Agency (EMEA). [...] But Pharming said it has followed up on and addressed concerns raised by the EMEA during the former evaluation procedure in 2007, adding that the size of the clinical database has been significantly expanded.